Skip to main content

Your Source for Leading Voices and Key Developments in EGFRm NSCLC

Trusted professionals delivering their expertise over popular topics from emerging data to pragmatic viewpoints.

Explore Leading Voices

Heather WakeleeDr. Heather WakeleeHelena A. YuDr. Helena A. YuSandip PatelDr. Sandip PatelMatthew LeeDr. Matthew LeeJonathan W. RiessDr. Jonathan W. RiessMillie DasDr. Millie Das

Featured post

Intercalated Gefitinib Plus Chemotherapy Improves DFS in Resected EGFR-Mutant NSCLC Infographic

September 18, 20261 min read

DISCOVER TRENDING TAGS

1L Treatment StrategiesOsimertinibTagrisso2L Treatment StrategiesAmivantamabTreatment Selection

Loading polls...

Clinical Updates Calendar

Mo
Tu
We
Th
Fr
Sa
Su
Anticipated Decisions
Approvals
Conferences
Designations
Events This Month

Funding for the EGFR Channel is provided by AstraZeneca. All content is developed independently by MJH Life Sciences; AstraZeneca has no influence on the content of the site.

© 2026 MJH Life Sciences. All rights reserved.

Home
Clinical Updates Calendar
View All Resources